OSE Immuno Welcomes Regulatory Success of Pegrizeprument in the United States
Veloxis Pharmaceuticals, partner of Nantes-based biotechnology company OSE Immuno, has reached a key milestone in the development of its innovative treatment against transplant rejection, paving the way for strategic advantages in the American market. OSE …